We are following the latest developments with COVID-19 and the recommendations by the Centers for Disease Control and Prevention. 

Tracy Rose, MD, MPH, Matthew Milowsky, MD, and colleagues report that the regimen reduced the invasiveness of the cancer in 56% of patients in a phase II clinical trial.

William Kim, MD, and colleagues have published findings that adding the experimental drug entinostat to an immunotherapy-like treatment substantially boosted cancer remission in laboratory models.

The Carolina Cancer Association is an organization for students studying biology to learn more about cancer and gain access to UNC Lineberger’s resources.

Rachel Hirschey, PhD, RN, will use the grant to create a behavioral intervention to increase physical activity among African Americans being treated for colorectal cancer.

Erin Kent, PhD, and Eliza (Leeza) Park, MD, are co-directing a project to help alleviate the burden that informal care places on caregivers, especially those in rural areas.

Lisa A. Carey, MD, FASCO, says the report shows significant progress in some areas, but also outlines important shortcomings, especially in eliminating cancer-related racial disparities.

Matthew Painschab, MD, and colleagues report that a five-drug combination chemotherapy provided curative benefit in people diagnosed with diffuse large B-cell lymphoma and is also a cost-effective option in Malawi.

Stephanie Wheeler, PhD, MPH, and Justin Trogdon, PhD, are co-authors of a study building upon previous metastatic breast cancer research on medical and productivity costs.

Antonio Amelio, PhD, received a grant to research the molecular mechanisms that control tumor cell differentiation in mucoepidermoid carcinomas, the most common type of salivary gland cancer.